Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?

Hossain, Sultana Mehbuba; Lynch-Sutherland, Chiemi F; Chatterjee, Aniruddha; Macaulay, Erin C; Eccles, Michael R

Hossain, Sultana Mehbuba; Lynch-Sutherland, Chiemi F; Chatterjee, Aniruddha; Macaulay, Erin C; Eccles, Michael R.

Afiliação

Hossain SM; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Lynch-Sutherland CF; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Chatterjee A; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Macaulay EC; Maurice Wilkins Centre for Molecular Biodiscovery, Level 2, 3A Symonds Street, Auckland 1010, New Zealand.
Eccles MR; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.

Epigenomes ; 5(3)2021 Jul 25.

Article em En | MEDLINE | ID: mdl-34968365

Palavras-chave

CTLA-4; DNA methylation; PD-1; PD-L1; T-cells; cancer; epigenetics; immune system; immunotherapy; placenta; transposable elements

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article